Matches in SemOpenAlex for { <https://semopenalex.org/work/W4292248792> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W4292248792 endingPage "1051" @default.
- W4292248792 startingPage "1047" @default.
- W4292248792 abstract "On May 17, 2022, the Food and Drug Administration (FDA) amended the Emergency Use Authorization (EUA) for BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine to authorize a homologous* booster dose for children aged 5-11 years ≥5 months after receipt of the second primary series dose† (1) based on findings from a clinical trial conducted among 401 children aged 5-11 years (2). To further characterize the safety of booster vaccination in this age group, CDC reviewed adverse events and health impact assessments after receipt of a Pfizer-BioNTech third dose reported to v-safe, a voluntary smartphone-based safety surveillance system for adverse events occurring after COVID-19 vaccination, and adverse events reported to the Vaccine Adverse Event Reporting System (VAERS), a passive vaccine safety surveillance system comanaged by CDC and FDA. During May 17-July 31, 2022, approximately 657,302 U.S. children aged 5-11 years received a third Pfizer-BioNTech dose (either a third primary series dose administered to immunocompromised children or a booster dose administered to immunocompetent children)§; 3,249 Pfizer-BioNTech third doses were reported to v-safe for children in this age group. Local and systemic reactions were reported to v-safe after a second dose and a third dose with similar frequency; some reactions (e.g., pain) were reported to be moderate or severe more frequently after a third dose. VAERS received 581 reports of adverse events after receipt of a Pfizer-BioNTech third dose by children aged 5-11 years; 578 (99.5%) reports were considered nonserious, and the most common events reported were vaccine administration errors. Three (0.5%) reports were considered serious; no reports of myocarditis or death were received. Local and systemic reactions were common among children after Pfizer-BioNTech third dose vaccination, but reports of serious adverse events were rare. Initial safety findings are consistent with those of the clinical trial (2)." @default.
- W4292248792 created "2022-08-19" @default.
- W4292248792 creator A5014457694 @default.
- W4292248792 creator A5017654848 @default.
- W4292248792 creator A5025817529 @default.
- W4292248792 creator A5026419626 @default.
- W4292248792 creator A5040342415 @default.
- W4292248792 creator A5048412798 @default.
- W4292248792 creator A5051327428 @default.
- W4292248792 creator A5059550323 @default.
- W4292248792 creator A5068468285 @default.
- W4292248792 creator A5073854301 @default.
- W4292248792 date "2022-08-19" @default.
- W4292248792 modified "2023-09-26" @default.
- W4292248792 title "Safety Monitoring of Pfizer-BioNTech COVID-19 Vaccine Booster Doses Among Children Aged 5–11 Years — United States, May 17–July 31, 2022" @default.
- W4292248792 cites W3212487860 @default.
- W4292248792 cites W4200320281 @default.
- W4292248792 cites W4207051048 @default.
- W4292248792 cites W4280635892 @default.
- W4292248792 cites W979396035 @default.
- W4292248792 doi "https://doi.org/10.15585/mmwr.mm7133a3" @default.
- W4292248792 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35980875" @default.
- W4292248792 hasPublicationYear "2022" @default.
- W4292248792 type Work @default.
- W4292248792 citedByCount "14" @default.
- W4292248792 countsByYear W42922487922022 @default.
- W4292248792 countsByYear W42922487922023 @default.
- W4292248792 crossrefType "journal-article" @default.
- W4292248792 hasAuthorship W4292248792A5014457694 @default.
- W4292248792 hasAuthorship W4292248792A5017654848 @default.
- W4292248792 hasAuthorship W4292248792A5025817529 @default.
- W4292248792 hasAuthorship W4292248792A5026419626 @default.
- W4292248792 hasAuthorship W4292248792A5040342415 @default.
- W4292248792 hasAuthorship W4292248792A5048412798 @default.
- W4292248792 hasAuthorship W4292248792A5051327428 @default.
- W4292248792 hasAuthorship W4292248792A5059550323 @default.
- W4292248792 hasAuthorship W4292248792A5068468285 @default.
- W4292248792 hasAuthorship W4292248792A5073854301 @default.
- W4292248792 hasBestOaLocation W42922487921 @default.
- W4292248792 hasConcept C121332964 @default.
- W4292248792 hasConcept C12590561 @default.
- W4292248792 hasConcept C126322002 @default.
- W4292248792 hasConcept C1276947 @default.
- W4292248792 hasConcept C159047783 @default.
- W4292248792 hasConcept C187212893 @default.
- W4292248792 hasConcept C197934379 @default.
- W4292248792 hasConcept C203165030 @default.
- W4292248792 hasConcept C22070199 @default.
- W4292248792 hasConcept C2522874641 @default.
- W4292248792 hasConcept C32611913 @default.
- W4292248792 hasConcept C71924100 @default.
- W4292248792 hasConceptScore W4292248792C121332964 @default.
- W4292248792 hasConceptScore W4292248792C12590561 @default.
- W4292248792 hasConceptScore W4292248792C126322002 @default.
- W4292248792 hasConceptScore W4292248792C1276947 @default.
- W4292248792 hasConceptScore W4292248792C159047783 @default.
- W4292248792 hasConceptScore W4292248792C187212893 @default.
- W4292248792 hasConceptScore W4292248792C197934379 @default.
- W4292248792 hasConceptScore W4292248792C203165030 @default.
- W4292248792 hasConceptScore W4292248792C22070199 @default.
- W4292248792 hasConceptScore W4292248792C2522874641 @default.
- W4292248792 hasConceptScore W4292248792C32611913 @default.
- W4292248792 hasConceptScore W4292248792C71924100 @default.
- W4292248792 hasIssue "33" @default.
- W4292248792 hasLocation W42922487921 @default.
- W4292248792 hasLocation W42922487922 @default.
- W4292248792 hasLocation W42922487923 @default.
- W4292248792 hasOpenAccess W4292248792 @default.
- W4292248792 hasPrimaryLocation W42922487921 @default.
- W4292248792 hasRelatedWork W1983816934 @default.
- W4292248792 hasRelatedWork W3048479924 @default.
- W4292248792 hasRelatedWork W3193791242 @default.
- W4292248792 hasRelatedWork W4205534188 @default.
- W4292248792 hasRelatedWork W4283450301 @default.
- W4292248792 hasRelatedWork W4283590592 @default.
- W4292248792 hasRelatedWork W4286253331 @default.
- W4292248792 hasRelatedWork W4311960398 @default.
- W4292248792 hasRelatedWork W4316466723 @default.
- W4292248792 hasRelatedWork W4321766608 @default.
- W4292248792 hasVolume "71" @default.
- W4292248792 isParatext "false" @default.
- W4292248792 isRetracted "false" @default.
- W4292248792 workType "article" @default.